Pharma Competitive Intelligence Briefs
Build your own
Type any drug into the URL:
https://druglandscape.com/ci/keytruda
Brand names auto-resolve. Add ?vs=drug1,drug2 for explicit comparators. Or use the feed builder.
Curated drug briefs by therapeutic area
Oncology
-
Keytruda PD-1
-
Opdivo PD-1
-
Tecentriq PD-L1
-
Imfinzi PD-L1
-
Enhertu HER2 ADC
-
Trodelvy TROP2 ADC
-
Ibrance CDK4/6
-
Verzenio CDK4/6
-
Kisqali CDK4/6
Metabolic
-
Ozempic / Wegovy GLP-1
-
Mounjaro / Zepbound GIP-GLP-1
-
Victoza / Saxenda GLP-1
-
Trulicity GLP-1
-
Jardiance SGLT-2
-
Farxiga SGLT-2
Cardiology
Immunology
Neurology
Sponsor-centric CI briefs
- Pfizer
- Merck & Co.
- Eli Lilly
- Novo Nordisk
- AstraZeneca
- Roche
- Novartis
- Sanofi
- GSK
- AbbVie
- Bristol-Myers Squibb
- Johnson & Johnson
- Amgen
- Gilead
- Regeneron
- Vertex
- Biogen
- Moderna
- BioNTech
- Takeda
Disease-centric CI briefs
- Breast cancerOncology
- NSCLCOncology
- Multiple myelomaOncology
- Colorectal cancerOncology
- Prostate cancerOncology
- MelanomaOncology
- LeukemiaOncology
- LymphomaOncology
- Ovarian cancerOncology
- Pancreatic cancerOncology
- ObesityMetabolic
- Type 2 diabetesMetabolic
- Heart failureCardiology
- Atrial fibrillationCardiology
- HypertensionCardiology
- Alzheimer's diseaseNeurology
- Parkinson's diseaseNeurology
- Multiple sclerosisNeurology
- Rheumatoid arthritisImmunology
- PsoriasisImmunology
- Atopic dermatitisImmunology
- Crohn's diseaseImmunology
- Ulcerative colitisImmunology
- AsthmaRespiratory
- COPDRespiratory
- Cystic fibrosisRespiratory
- HIVInfectious
How it works
- Pick a target drug by brand or generic name (canonical slug used internally).
- Auto-detect comparators — shared molecular target first, then drug class, then therapeutic area. Capped at 6.
- Join events across the set — regulatory actions (last 90d), PDUFA dates (next 180d), Phase 3 trial readouts, patent expiries.
- Subscribe — every brief has a paired RSS / Atom / JSON feed for ongoing monitoring.
Why CI briefs matter for pharma teams
- BD / corp dev — quickly map a target asset against its competitive set before pursuing a deal
- Medical affairs — track upcoming readouts in your therapeutic area
- Market access — patent timeline + comparator pricing in one view
- Investor research — sponsor landscape + recent regulatory actions per drug class
- Strategy / planning — early-warning system for class-wide regulatory events
Subscribe to all CI activity
If you'd rather get every CI-worthy event across all tracked drugs rather than one specific brief:
- Recent approvals firehose (RSS)
- Upcoming PDUFA dates (RSS)
- Phase 3 readouts (RSS)
- Full pharma firehose (200 items)
- Build a custom filter
For developers
Need CI data programmatically?